NASDAQ:VXRT

Vaxart News Headlines

$8.50
-0.24 (-2.75 %)
(As of 06/14/2021 02:21 PM ET)
Add
Compare
Today's Range
$8.34
$9.68
50-Day Range
$5.06
$10.78
52-Week Range
$2.26
$24.90
Volume580,519 shs
Average Volume5.34 million shs
Market Capitalization$1.04 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.3

Vaxart (NASDAQ VXRT) News Headlines Today

SourceHeadline
Meme stock rally pauses, Redditors focus on biotech stocks - Reuters'Meme stock' rally pauses, Redditors focus on biotech stocks - Reuters
reuters.com - June 14 at 10:07 AM
Why Vaxart Stock Is Skyrocketing Today - The Motley FoolWhy Vaxart Stock Is Skyrocketing Today - The Motley Fool
fool.com - June 12 at 9:34 AM
Vaxart Has A More Sound Reason To Buy Into Its COVID-19 Vaccine Candidate - Seeking AlphaVaxart Has A More Sound Reason To Buy Into Its COVID-19 Vaccine Candidate - Seeking Alpha
seekingalpha.com - June 11 at 6:33 PM
Insider Selling: Vaxart, Inc. (NASDAQ:VXRT) SVP Sells 47,555 Shares of StockInsider Selling: Vaxart, Inc. (NASDAQ:VXRT) SVP Sells 47,555 Shares of Stock
americanbankingnews.com - June 11 at 5:48 PM
5 Top Stock Gainers for Friday: Novan, Magnachip, Vaxart - TheStreet5 Top Stock Gainers for Friday: Novan, Magnachip, Vaxart - TheStreet
thestreet.com - June 11 at 1:33 PM
Why Vaxart Stock Is Skyrocketing Today - NasdaqWhy Vaxart Stock Is Skyrocketing Today - Nasdaq
nasdaq.com - June 11 at 1:33 PM
Vaxart (NASDAQ:VXRT) Sees Large Volume IncreaseVaxart (NASDAQ:VXRT) Sees Large Volume Increase
americanbankingnews.com - June 11 at 12:42 PM
Vaxart (NASDAQ:VXRT) Now Covered by Analysts at Piper SandlerVaxart (NASDAQ:VXRT) Now Covered by Analysts at Piper Sandler
americanbankingnews.com - June 11 at 8:38 AM
Bet on a No-Needle Vaccine Strategy with Vaxart - NasdaqBet on a No-Needle Vaccine Strategy with Vaxart - Nasdaq
nasdaq.com - June 11 at 8:32 AM
Vaxart, Inc. (NASDAQ:VXRT) Expected to Announce Quarterly Sales of $650,000.00Vaxart, Inc. (NASDAQ:VXRT) Expected to Announce Quarterly Sales of $650,000.00
americanbankingnews.com - June 11 at 3:46 AM
Zacks: Analysts Anticipate Vaxart, Inc. (NASDAQ:VXRT) Will Post Quarterly Sales of $650,000.00Zacks: Analysts Anticipate Vaxart, Inc. (NASDAQ:VXRT) Will Post Quarterly Sales of $650,000.00
americanbankingnews.com - June 11 at 3:46 AM
Why Shares of Vaxart Plummeted 38.6% in May - Motley FoolWhy Shares of Vaxart Plummeted 38.6% in May - Motley Fool
fool.com - June 10 at 7:14 PM
Why Shares of Vaxart Plummeted 38.6% in May - NasdaqWhy Shares of Vaxart Plummeted 38.6% in May - Nasdaq
nasdaq.com - June 10 at 2:10 PM
Why Shares of Vaxart Plummeted 38.6% in MayWhy Shares of Vaxart Plummeted 38.6% in May
finance.yahoo.com - June 10 at 2:10 PM
Vaxart Stock Is Estimated To Be Significantly Overvalued - Yahoo FinanceVaxart Stock Is Estimated To Be Significantly Overvalued - Yahoo Finance
finance.yahoo.com - June 10 at 12:13 AM
Bet on a No-Needle Vaccine Strategy with Vaxart - InvestorPlaceBet on a No-Needle Vaccine Strategy with Vaxart - InvestorPlace
investorplace.com - June 9 at 7:13 PM
Vaxart (NASDAQ:VXRT) Shares Up 6.6%Vaxart (NASDAQ:VXRT) Shares Up 6.6%
americanbankingnews.com - June 9 at 11:34 AM
Vaxart, Inc. (NASDAQ:VXRT) Expected to Announce Earnings of -$0.14 Per ShareVaxart, Inc. (NASDAQ:VXRT) Expected to Announce Earnings of -$0.14 Per Share
americanbankingnews.com - June 9 at 9:28 AM
Vaxart (NASDAQ:VXRT) Shares Gap Up to $7.34Vaxart (NASDAQ:VXRT) Shares Gap Up to $7.34
americanbankingnews.com - June 8 at 11:00 AM
5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street - Motley Fool5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street - Motley Fool
fool.com - June 8 at 7:10 AM
These Vaccine Latecomers Could Still Win Big. Heres How - NasdaqThese Vaccine Latecomers Could Still Win Big. Here's How - Nasdaq
nasdaq.com - June 8 at 7:10 AM
5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street
finance.yahoo.com - June 8 at 7:10 AM
These Vaccine Latecomers Could Still Win Big. Heres How - Motley FoolThese Vaccine Latecomers Could Still Win Big. Here's How - Motley Fool
fool.com - June 7 at 3:30 PM
These Vaccine Latecomers Could Still Win Big. Heres HowThese Vaccine Latecomers Could Still Win Big. Here's How
finance.yahoo.com - June 7 at 3:30 PM
Vaxart to Present at the SVB Leerink CybeRx Series: Vaccine ForumVaxart to Present at the SVB Leerink CybeRx Series: Vaccine Forum
finance.yahoo.com - June 7 at 10:30 AM
Vaxarts Compelling Story Will Take a Long Time to Play Out - InvestorPlaceVaxart's Compelling Story Will Take a Long Time to Play Out - InvestorPlace
investorplace.com - June 3 at 2:31 PM
Vaxart (NASDAQ:VXRT) Trading Up 8.5%Vaxart (NASDAQ:VXRT) Trading Up 8.5%
americanbankingnews.com - June 2 at 1:00 PM
Speculators Should Consider Buying Vaxart Stock - NasdaqSpeculators Should Consider Buying Vaxart Stock - Nasdaq
nasdaq.com - May 28 at 9:26 AM
Speculators Should Consider Buying Vaxart Stock - InvestorPlaceSpeculators Should Consider Buying Vaxart Stock - InvestorPlace
investorplace.com - May 26 at 6:38 PM
Vaxart (NASDAQ:VXRT)  Shares Down 5.7% Vaxart (NASDAQ:VXRT) Shares Down 5.7%
americanbankingnews.com - May 24 at 1:00 PM
$650,000.00 in Sales Expected for Vaxart, Inc. (NASDAQ:VXRT) This Quarter$650,000.00 in Sales Expected for Vaxart, Inc. (NASDAQ:VXRT) This Quarter
americanbankingnews.com - May 23 at 1:48 AM
Vaxart, Inc. (NASDAQ:VXRT) Expected to Post Earnings of -$0.14 Per ShareVaxart, Inc. (NASDAQ:VXRT) Expected to Post Earnings of -$0.14 Per Share
americanbankingnews.com - May 21 at 6:20 PM
Vaxart Could Still Be a Viable Covid 19 Vaccine Play - Investorplace.comVaxart Could Still Be a Viable Covid 19 Vaccine Play - Investorplace.com
investorplace.com - May 18 at 11:42 PM
It Wont Take Much for Vaxart Stock to Pop Once Again - InvestorPlaceIt Won't Take Much for Vaxart Stock to Pop Once Again - InvestorPlace
investorplace.com - May 14 at 4:18 PM
Does Vaxart Deserve a Place in Your Portfolio? - Yahoo FinanceDoes Vaxart Deserve a Place in Your Portfolio? - Yahoo Finance
finance.yahoo.com - May 13 at 1:14 PM
Is Vaxart a Buy? - NasdaqIs Vaxart a Buy? - Nasdaq
nasdaq.com - May 12 at 5:08 PM
Is Vaxart a Buy? - Motley FoolIs Vaxart a Buy? - Motley Fool
fool.com - May 12 at 7:07 AM
Vaxarts No-Shot Vaccine Is a Potential Game Changer - InvestorPlaceVaxart's No-Shot Vaccine Is a Potential Game Changer - InvestorPlace
investorplace.com - May 11 at 4:04 PM
Is Vaccine Maker Vaxart Worth Holding From Here? - Motley FoolIs Vaccine Maker Vaxart Worth Holding From Here? - Motley Fool
fool.com - May 9 at 5:58 PM
Is Vaccine Maker Vaxart Worth Holding From Here?Is Vaccine Maker Vaxart Worth Holding From Here?
finance.yahoo.com - May 9 at 5:57 PM
Enrollment underway in Vaxarts early-stage norovirus trial in elderly population - Seeking AlphaEnrollment underway in Vaxart's early-stage norovirus trial in elderly population - Seeking Alpha
seekingalpha.com - May 7 at 5:32 PM
Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Dose-Ranging Trial in Elderly Adults - GlobeNewswireVaxart Announces First Subject Enrolled in Phase 1b Norovirus Dose-Ranging Trial in Elderly Adults - GlobeNewswire
globenewswire.com - May 7 at 12:31 PM
Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Dose-Ranging Trial in Elderly AdultsVaxart Announces First Subject Enrolled in Phase 1b Norovirus Dose-Ranging Trial in Elderly Adults
finance.yahoo.com - May 7 at 12:31 PM
Better Vaccine Stock: Ocugen or Vaxart? - Motley FoolBetter Vaccine Stock: Ocugen or Vaxart? - Motley Fool
fool.com - May 7 at 7:31 AM
Better Vaccine Stock: Ocugen or Vaxart?Better Vaccine Stock: Ocugen or Vaxart?
finance.yahoo.com - May 7 at 7:31 AM
Vaxart (VXRT) Reports First Patient Enrollment in Phase 1b Norovirus Boosting Regimen Study - StreetInsider.comVaxart (VXRT) Reports First Patient Enrollment in Phase 1b Norovirus Boosting Regimen Study - StreetInsider.com
streetinsider.com - May 6 at 4:25 AM
Why Vaxart Stock Is Surging Today - The Motley FoolWhy Vaxart Stock Is Surging Today - The Motley Fool
fool.com - May 4 at 8:00 PM
Why Vaxart Shares Popped 78% in AprilWhy Vaxart Shares Popped 78% in April
finance.yahoo.com - May 4 at 2:59 PM
New Berkshire Boss, Dell, Vaxart, Ethereum – On TheStreet Monday - TheStreetNew Berkshire Boss, Dell, Vaxart, Ethereum – On TheStreet Monday - TheStreet
thestreet.com - May 3 at 6:58 PM
Earning roundup: Estée Lauder sales jump 16%, Vaxart COVID-19 vaccine trial start delayed - Yahoo FinanceEarning roundup: Estée Lauder sales jump 16%, Vaxart COVID-19 vaccine trial start delayed - Yahoo Finance
finance.yahoo.com - May 3 at 6:58 PM
This page was last updated on 6/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.